- Focus and Scope
- Section Policies
- Peer Review Process
- Publication Frequency
- Open Access Policy
- Editorial Policies
- Authorship
- Conflict of Interest
- Plagiarism
- Publication Fees
- Language
- Language Editing Services
- Submission of Revised Manuscripts
- Withdrawal of Manuscript
- Supporting Information
- Indexing and Archiving
- Publishing Policies
Focus and Scope
The journal, Advances in Precision Medicine (APM) brings together all aspects of the rapidly growing field of personalized/ precision medicine.
APM welcome the manuscript from all the field of precision medicine including genomic research (SNPs, CNVs, and Structure variants), epigenetic research (DNA, histone, mRNA and other protein modifications) and transcriptomic, proteomic and metabolomic research which are aimed to improve the understanding of etiology and pathology of human disease and to improve the disease therapy. We highly welcome the studies with the strategy of genome-wide, multi-omics and single-cell level such as GWAS, WGBS, EWAS, PheWAS, scRNA-seq, PGx and PGEx research. Biomarkers are a key focus of APM’s scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmaco-dynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.
Articles include original articles, reviews, perspectives, editorials, commentaries, position papers, conference reports and letters to the editor. APM will also consider publishing negative data. The journal welcomes unsolicited article proposals in all categories except for “Editorials”. Authors are encouraged to refer to APM’s “Section Policies” for more information.APM provides a vital forum for the exchange of important information in all areas of personalized medicine and biomarker research, development and application.
We are devoted to making APM a high-quality, frequently cited journal that publishes superior scholarly articles and disseminates the latest advances in the field. The target audiences of APM are the scientific and healthcare communities of basic scientists and clinicians from academia, regulatory institutions, and industry. This includes pharma, diagnostic and device companies.
Section Policies
Original Articles
Scientific articles on original basic and applied research and/or analysis.
This manuscript type typically has 5 tables and figures in total, and approximately 40 references and 7,000 words (inclusive of reference list and abstract).
![]() |
![]() |
![]() |
Review Articles
A summary highlighting recent developments and current/future trends of the field.
This manuscript type typically has 5 tables and figures in total, and approximately 70 references and 7,000 words (inclusive of reference list and abstract).
![]() |
![]() |
![]() |
Perspective Articles
These are author’s personal opinions on a subject/topic. Unlike Reviews, Perspective Articles may cover a more specific, narrow part of the field. However, these manuscripts are still required to uphold the spirit of academia to be objective as well as aim to initiate or further discussions and novel experimental procedures in the field.
This manuscript type typically has 5 tables and figures in total, and approximately 40 references and 5,000 words (inclusive of reference list and abstract).
![]() |
![]() |
![]() |
Letters to the Editor-in-Chief
Comments from reader(s) about individual articles. These letters must be constructive and contribute to the development of individual articles published or the entire journal. Letters containing new ideas, supporting data or data criticizing any articles may be subjected to peer review (determined on a case-by-case basis by the journal’s editorial team) and published in the online publication but not in the printed version.
This manuscript type typically has 1,800 words (exclusive of reference list)
![]() |
![]() |
![]() |
Editorials
Solicited concise commentary highlighting prominent topics in the journal issue. These are the official opinions of the editors of the journal or special issue. Editorials will be published in both the online and printed versions of the journal.
This manuscript type typically has 3,500 words. Authors are welcome to propose ideas/themes to the Editor-in-Chief.
![]() |
![]() |
![]() |
Commentaries
Unsolicited commentaries or analysis from reader(s) targeting specific published articles in the journal. Commentaries will be subjected to peer review and may be published in both online and printed versions of the journal.
This manuscript type typically has 3,500 words.
![]() |
![]() |
![]() |
Conference Reports
Solicited reports from topic-related conferences, meetings, and congresses that are of interest to readers such as novel trends and perspectives. Such reports will be subjected to peer review and may be published in both online and printed versions of the journal. Authors are welcome to propose ideas for such articles to the Editor-in-Chief for consideration.
This manuscript type typically has 3,500 words.
![]() |
![]() |
![]() |
Position Papers
Submissions that reflect the official opinion of an organization (e.g. government bodies, funding agencies etc.)
This manuscript type typically has 3,500 words.
![]() |
![]() |
![]() |
Peer Review Process
All manuscripts submitted to Advances in Precision Medicine will follow the following procedure:
- Initial submission are reviewed by in-house editors to ensure adherence to journal policies
- Editor-in-chief decides on the manuscript to be sent out for review process and assigns the manuscript to one of the editors according to the particular topic.
- Editor assigns reviewers from inside the editorial board or outside depending on the topic.
- After evaluations by the reviewers have been received, the editor-in-chief makes one of the following recommendations: accept, minor revision, major revision, reject and resubmit, and reject. Unless otherwise requested by the Editor-in-Chief, the following time frames will be used.
- If decision is “minor revision”, the authors have 4 weeks to resubmit the revised manuscript.
- If decision is “major revision”, the authors have 2 months to resubmit the revised manuscript.
- Upon resubmission, the same procedure is applied as for the initial submission.
- Authors may appeal for a rejected submission. Appeal requests must be made in writing to apm@whioce.com with detailed reasons for the appeal and point by point responses to the reviewer’s remarks. Decisions on appeals are final without exception.
- For all manuscripts accepted for publication, the peer review process will be deemed to be completed. The manuscript will proceed to be copyedited, layout edited and proofread before being published online.
Publication Frequency
bi-annual
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Editorial Policies
A manuscript would not be accepted if it has been published or is currently under consideration for publication in any other journals. The author will need to notify the editorial team if the data in their submission has been presented in conferences.
After acceptance, the Publisher will have the right to edit the work for the original edition and for any revision.
Authorship
Authorship should be limited to people who have contributed substantially to the work. Authors must indicate their specific contributions to the published work. This information should be listed in the manuscript under the section ‘Author Contribution’. Examples of contributions include: designed research, performed research, contributed new reagents or analytic tools, analyzed data, wrote the paper.
For more information on submission’s format, please refer to the ‘Author Guidelines’ link accessible from the ‘About’ button at the top row of this page.
The corresponding author should be clearly indicated for all manuscripts submitted. A maximum of two corresponding authors are allowed for the responsibilities associated. The corresponding author(s) is responsible for:
- Obtaining permission from all the authors mentioned in the manuscript
- Ensuring adherence to all editorial and submission policies and for any communications and actions that may be necessary after publication
- Including written permission from the authors of the work concerned for any mention of any unpublished material included in the manuscript, e.g. data from manuscripts-in-press, personal communication, or work in preparation.
Conflict of Interest
The author has to provide the authorization of no conflict with any financial body or funding agency that might influence the results or interpretation of their manuscript. Any conflict of interest on the part of author(s) must be declared within the submitted manuscript before being published.
Apart from authors, members, reviewers and editors must also disclose any association that poses a conflict of interest in connection with the manuscript.
Plagiarism
The editorial team does not approve of any plagiarism attempts. Plagiarism detection software will be utilized at the editor’s discretion to verify the originality of submitted manuscripts. If plagiarism is detected during the review process the manuscript may be rejected depending on the severity of plagiarism. Therefore, if a manuscript uses a text copied directly from another source, this text must be written in quotation marks and the original source must be cited.
Publication Fees
The publication fees for each manuscript accepted for publication is USD 800 for 6 pages. This fee is meant to support the open access journal’s associated expenses. The editorial team will have the right to assume that authors submitting their manuscripts for publication consents to paying the publication fee upon acceptance for publication unless given a written waiver from both the Editor-in-Chief and the Publisher.
Language
All articles should be written in English—either British or American as long as consistency is observed. SI units should be used. If you are not a native English speaker, you may want to utilize an external or Whioce Publishing’s optional professional language editing service before submitting the final version.
Language Editing Services
Whioce Publishing Pte Ltd offers its own professional editing services. By using this service, you can be sure that your English-language manuscript will be polished and ready for submission to your publication of choice at a very reasonable price. For further details about the Language Editing Services, please contact us at academic@whioce.com. Please note that utilizing a language editing service is not a guarantee of acceptance.
Submission of Revised Manuscripts
Revised manuscripts must contain a detailed point by point response to the comments of the reviewers. The response to reviewers has to be uploaded as a separate file.
Withdrawal of Manuscript
If you withdraw your manuscript after it has been accepted (but not yet published), you will be charged for costs incurred at USD200.
Supporting Information
Authors are expected to have minimal amount of post-acquisition processing of data. In case of processing, alterations must be applied to the entire image (e.g., brightness, contrast, color balance). Any kind of alteration if being done has to be clearly stated in the figure legend and in the Materials and Methods section.
Grouping of data (e.g., cropping of images of removal of lanes from gels and bolts) must be made apparent and should be explicitly indicated in the appropriate figure legends. Data comparisons should only be made from comparative experiments, and individual data should not be utilized across multiple figures. If inappropriate image/data manipulation is identified after publication, we reserve the right to ask for the original data and, if that is not satisfactory, to issue a correction or retract the paper as appropriate.
Indexing and Archiving
Advances in Precision Medicine (APM) aims to be indexed by world-recognized databases, for example, PubMed, Scopus and Science Citation Index (SCI). APM has been indexed and archived by several databases:
- CNKI Scholar (中国知网)
- Crossref
- Google Scholar
- JournalTOCs
- National Library Board of Singapore
- Portico
- Scilit
- Worldcat
Publishing Policies
Whioce Publishing requests all members involved in the journal publishing process to adhere to the Core Practices on publication ethics as stipulated by COPE (Committee on Publication Ethics).
The publisher strictly adheres to the guidelines and best practices, which include Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journals Editors (ICMJE) and the Principles of Transparency and Best Practice in Scholarly Publishing developed by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA) and World Association of Medical Editors (WAME).
All complaints submitted by the authors to the journal will be addressed promptly according to the procedure set out in the COPE flowchart on complaints. The complainant may direct all inquiries and correspondence to the publisher at editorial@whioce.com.